<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35450623</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-1344</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>288</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jul</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Carbohydrate polymers</Title>
          <ISOAbbreviation>Carbohydr Polym</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Advances in the colon-targeted chitosan based multiunit drug delivery systems for the treatment of inflammatory bowel disease.</ArticleTitle>
        <Pagination>
          <StartPage>119351</StartPage>
          <MedlinePgn>119351</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.carbpol.2022.119351</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0144-8617(22)00255-7</ELocationID>
        <Abstract>
          <AbstractText>Chitosan is the polymer of choice for delivery of the active moieties to the colon due to its cationic nature that enables strong mucosal attachment. Chitosan is explored for formulations such as pellets, beads, microspheres, nanoparticles and drug-polymer conjugates for colon targeting of various therapeutic agents in inflammatory bowel disease (IBD). The major challenge in the colonic delivery of drugs in IBD is altered physiological pH, which can be addressed via chitosan containing multiparticulate drug delivery systems owing to their biodegradability in the colon. Its ionic interaction with anionic polymers forms gastro-resistant multi-unit systems that ensures safe delivery of payloads to the colon. In contrast to commercial grade gastro-resistant polymers, chitosan has GRAS (generally regarded as safe) status that ensures safety for long-term therapy in case of chronic diseases such as IBD. Here, we review in detail essential properties of chitosan and chitosan based multiunit formulations for treatment/mitigation of IBD.</AbstractText>
          <CopyrightInformation>Copyright Â© 2022 Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kulkarni</LastName>
            <ForeName>Nilesh</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, R. C. Patel Institute of Pharmaceutical Education and Research, Karwand Naka, Shirpur, 425405, Dist. Dhule, Maharashtra, India. Electronic address: nilesh.kulkarni9@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jain</LastName>
            <ForeName>Priti</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University (DPSRU-Govt. of NCT Delhi), Mehrauli-Badarpur Road, Pushp Vihar Sector 3, New Delhi, 110017, India. Electronic address: pritijain@dpsru.edu.in.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shindikar</LastName>
            <ForeName>Amol</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>In-charge, Central Research Laboratory, MGM Medical College and Hospital, MGM Campus, N-6, CIDCO, Aurangabad, 431003 (A constituent college of MGMIHS, Navi Mumbai), Maharashtra, India; Cluster of Drug Discovery, Development and Translational Research, Center of Multidisciplinary Research (CMR), MGM University, Aurangabad, 431003, Maharashtra, India; Department of Pharmaceutical Sciences, Birla Institute of Technology and Science (BITS), Pilani, 333031, Rajasthan, India. Electronic address: crliic@mgmmcha.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suryawanshi</LastName>
            <ForeName>Pravin</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Center of Excellence for Endoscopy and Advanced Minimally Invasive Surgery, Department of Surgery and Gastroenterology, MGM Medical Center and Research Institute, Aurangabad, 431003, Maharashtra, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thorat</LastName>
            <ForeName>Nanasaheb</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Cluster of Drug Discovery, Development and Translational Research, Center of Multidisciplinary Research (CMR), MGM University, Aurangabad, 431003, Maharashtra, India; Nuffield Department of Women's and Reproductive Health, John Radcliffe Hospital, Medical Sciences Division, University of Oxford, Oxford OX3 9DU, United Kingdom. Electronic address: thoratnd@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Carbohydr Polym</MedlineTA>
        <NlmUniqueID>8307156</NlmUniqueID>
        <ISSNLinking>0144-8617</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004337">Drug Carriers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011108">Polymers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9012-76-4</RegistryNumber>
          <NameOfSubstance UI="D048271">Chitosan</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D048271" MajorTopicYN="Y">Chitosan</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004337" MajorTopicYN="N">Drug Carriers</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016503" MajorTopicYN="N">Drug Delivery Systems</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015212" MajorTopicYN="Y">Inflammatory Bowel Diseases</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011108" MajorTopicYN="N">Polymers</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">5-Aminosalicylic acid (4075)</Keyword>
        <Keyword MajorTopicYN="N">Biopolymers</Keyword>
        <Keyword MajorTopicYN="N">Carboxymethyl cellulose sodium (23706213)</Keyword>
        <Keyword MajorTopicYN="N">Chitosan</Keyword>
        <Keyword MajorTopicYN="N">Chitosan (7057928)</Keyword>
        <Keyword MajorTopicYN="N">Colon targeting</Keyword>
        <Keyword MajorTopicYN="N">Dextran sulphate (4125253)</Keyword>
        <Keyword MajorTopicYN="N">Eudragit S-100 (65358)</Keyword>
        <Keyword MajorTopicYN="N">Inflammatory bowel disease</Keyword>
        <Keyword MajorTopicYN="N">Multiparticulate drug delivery</Keyword>
        <Keyword MajorTopicYN="N">Pectin (5381226)</Keyword>
        <Keyword MajorTopicYN="N">Sodium alginate</Keyword>
        <Keyword MajorTopicYN="N">Sodium alginate (5102882)</Keyword>
        <Keyword MajorTopicYN="N">Sodium tripolyphosphate (24455)</Keyword>
        <Keyword MajorTopicYN="N">Starch (24836924)</Keyword>
        <Keyword MajorTopicYN="N">Xanthan gum (131750926)</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>7</Hour>
          <Minute>2</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35450623</ArticleId>
        <ArticleId IdType="doi">10.1016/j.carbpol.2022.119351</ArticleId>
        <ArticleId IdType="pii">S0144-8617(22)00255-7</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
